Veterinaria
Fakultät
Hospital Universitario Central de Asturias
Oviedo, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital Universitario Central de Asturias (17)
2023
-
Recommendations of the Spanish Antibiogram Committee (COESANT) for in vitro susceptibility testing of antimicrobial agents by disk diffusion
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 9, pp. 571-576
2022
-
Mechanical ventilation in patients with cardiogenic pulmonary edema: a sub-analysis of the LUNG SAFE study
Journal of Intensive Care, Vol. 10, Núm. 1
2019
-
Fecal Changes Following Introduction of Milk in Infants With Outgrowing Non-IgE Cow's Milk Protein Allergy Are Influenced by Previous Consumption of the Probiotic LGG
Frontiers in immunology, Vol. 10, pp. 1819
-
Rationale and Study Design for an Individualized Perioperative Open Lung Ventilatory Strategy in Patients on One-Lung Ventilation (iPROVE-OLV)
Journal of Cardiothoracic and Vascular Anesthesia, Vol. 33, Núm. 9, pp. 2492-2502
-
Reply: “letter to the editor re: Diaz M., et al. nutrients 2018, 10, 1481"
Nutrients
2018
-
Immunocompromised patients with acute respiratory distress syndrome: Secondary analysis of the LUNG SAFE database
Critical Care, Vol. 22, Núm. 1
-
Impact of co-infection by hepatitis C virus on immunological and virological response to antiretroviral therapy in HIV-positive patients
Medicine (United States), Vol. 97, Núm. 38
-
Low-level viremia is associated with clinical progression in HIV-infected patients receiving antiretroviral treatment
Journal of Acquired Immune Deficiency Syndromes, Vol. 78, Núm. 3, pp. 329-337
-
Microbiota and derived parameters in fecal samples of infants with Non-IgE cow’s milk protein allergy under a restricted diet
Nutrients, Vol. 10, Núm. 10
2017
-
Simplification to dual therapy (atazanavir/ritonavir1lamivudine) versus standard triple therapy [atazanavir/ritonavir1two nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study)
Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 1, pp. 246-253
2016
-
Molecular and epidemiological population-based integrative analysis of human and animal Mycobacterium bovis infections in a low-prevalence setting
Veterinary Microbiology, Vol. 195, pp. 30-36
2015
-
Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial
The Lancet Infectious Diseases, Vol. 15, Núm. 7, pp. 775-784
2011
-
Humans as source of Mycobacterium tuberculosis infection in cattle, Spain
Emerging Infectious Diseases
2009
-
Biological differences between in vitro produced bovine embryos and parthenotes
Reproduction, Vol. 137, Núm. 2, pp. 285-295
-
Occurrence of extended-spectrum beta-lactamase producing Salmonella enterica in North Spain with evidence of CTX-M-9 clonal spread among animals and humans
Clinical Microbiology and Infection, Vol. 15, Núm. 3, pp. 292-295
2008
2007
-
Evolution of the antimicrobial resistance of Pseudomonas aeruginosa in Spain: Second National Study (2003)
Revista Espanola de Quimioterapia, Vol. 20, Núm. 2, pp. 222-229